Interference of immune globulin with measles and rubella immunization

G. R. Siber, B. G. Werner, Neal A Halsey, Raymond Reid, J. Almeido-Hill, S. C. Garrett, C. Thompson, Mathuram Santosham

Research output: Contribution to journalArticle

Abstract

Passively acquired antibody may interfere with the active antibody response to live viral vaccines such as measles and rubella. To evaluate the duration of this inhibitory effect, we measured the measles and rubella antibody responses of Apache children immunized with measles, mumps, and rubella vaccine at varying intervals after administration of an immune globulin termed bacterial polysaccharide immune globulin (BPIG). This specific immune globulin contained measles and rubella antibody titers similar to those in standard intramuscularly and intravenously administered immune globulins. Antibody responses to measles vaccine were inhibited for up to 5 months after a BPIG dose of 80 mg IgG per kilogram of body weight, but responses to rubella vaccine were inhibited for only 2 months. Most children who had a decreased measles antibody response to primary measles, mumps, and rubella immunization given 1 1/2 to 4 months after BPIG administration responded to a booster immunization given 6 months after their last BPIG dose. We conclude that high doses of immune globulin (>10 mg/kg) may inhibit the antibody response to measles for more than 3 months. We propose that the interval between administration of immune globulin and measles and rubella immunization be adjusted on the basis of the dose of immune globulin.

Original languageEnglish (US)
Pages (from-to)204-211
Number of pages8
JournalJournal of Pediatrics
Volume122
Issue number2
StatePublished - 1993

Fingerprint

Rubella
Measles
Immunoglobulins
Immunization
Antibody Formation
Rubella Vaccine
Measles-Mumps-Rubella Vaccine
Viral Vaccines
Measles Vaccine
Secondary Immunization
Mumps
Immunoglobulin G
Body Weight
bacterial polysaccharide immune globulin
Antibodies

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health

Cite this

Siber, G. R., Werner, B. G., Halsey, N. A., Reid, R., Almeido-Hill, J., Garrett, S. C., ... Santosham, M. (1993). Interference of immune globulin with measles and rubella immunization. Journal of Pediatrics, 122(2), 204-211.

Interference of immune globulin with measles and rubella immunization. / Siber, G. R.; Werner, B. G.; Halsey, Neal A; Reid, Raymond; Almeido-Hill, J.; Garrett, S. C.; Thompson, C.; Santosham, Mathuram.

In: Journal of Pediatrics, Vol. 122, No. 2, 1993, p. 204-211.

Research output: Contribution to journalArticle

Siber, GR, Werner, BG, Halsey, NA, Reid, R, Almeido-Hill, J, Garrett, SC, Thompson, C & Santosham, M 1993, 'Interference of immune globulin with measles and rubella immunization', Journal of Pediatrics, vol. 122, no. 2, pp. 204-211.
Siber GR, Werner BG, Halsey NA, Reid R, Almeido-Hill J, Garrett SC et al. Interference of immune globulin with measles and rubella immunization. Journal of Pediatrics. 1993;122(2):204-211.
Siber, G. R. ; Werner, B. G. ; Halsey, Neal A ; Reid, Raymond ; Almeido-Hill, J. ; Garrett, S. C. ; Thompson, C. ; Santosham, Mathuram. / Interference of immune globulin with measles and rubella immunization. In: Journal of Pediatrics. 1993 ; Vol. 122, No. 2. pp. 204-211.
@article{85781eb709d84a0ba78d23425318dea4,
title = "Interference of immune globulin with measles and rubella immunization",
abstract = "Passively acquired antibody may interfere with the active antibody response to live viral vaccines such as measles and rubella. To evaluate the duration of this inhibitory effect, we measured the measles and rubella antibody responses of Apache children immunized with measles, mumps, and rubella vaccine at varying intervals after administration of an immune globulin termed bacterial polysaccharide immune globulin (BPIG). This specific immune globulin contained measles and rubella antibody titers similar to those in standard intramuscularly and intravenously administered immune globulins. Antibody responses to measles vaccine were inhibited for up to 5 months after a BPIG dose of 80 mg IgG per kilogram of body weight, but responses to rubella vaccine were inhibited for only 2 months. Most children who had a decreased measles antibody response to primary measles, mumps, and rubella immunization given 1 1/2 to 4 months after BPIG administration responded to a booster immunization given 6 months after their last BPIG dose. We conclude that high doses of immune globulin (>10 mg/kg) may inhibit the antibody response to measles for more than 3 months. We propose that the interval between administration of immune globulin and measles and rubella immunization be adjusted on the basis of the dose of immune globulin.",
author = "Siber, {G. R.} and Werner, {B. G.} and Halsey, {Neal A} and Raymond Reid and J. Almeido-Hill and Garrett, {S. C.} and C. Thompson and Mathuram Santosham",
year = "1993",
language = "English (US)",
volume = "122",
pages = "204--211",
journal = "Journal of Pediatrics",
issn = "0022-3476",
publisher = "Mosby Inc.",
number = "2",

}

TY - JOUR

T1 - Interference of immune globulin with measles and rubella immunization

AU - Siber, G. R.

AU - Werner, B. G.

AU - Halsey, Neal A

AU - Reid, Raymond

AU - Almeido-Hill, J.

AU - Garrett, S. C.

AU - Thompson, C.

AU - Santosham, Mathuram

PY - 1993

Y1 - 1993

N2 - Passively acquired antibody may interfere with the active antibody response to live viral vaccines such as measles and rubella. To evaluate the duration of this inhibitory effect, we measured the measles and rubella antibody responses of Apache children immunized with measles, mumps, and rubella vaccine at varying intervals after administration of an immune globulin termed bacterial polysaccharide immune globulin (BPIG). This specific immune globulin contained measles and rubella antibody titers similar to those in standard intramuscularly and intravenously administered immune globulins. Antibody responses to measles vaccine were inhibited for up to 5 months after a BPIG dose of 80 mg IgG per kilogram of body weight, but responses to rubella vaccine were inhibited for only 2 months. Most children who had a decreased measles antibody response to primary measles, mumps, and rubella immunization given 1 1/2 to 4 months after BPIG administration responded to a booster immunization given 6 months after their last BPIG dose. We conclude that high doses of immune globulin (>10 mg/kg) may inhibit the antibody response to measles for more than 3 months. We propose that the interval between administration of immune globulin and measles and rubella immunization be adjusted on the basis of the dose of immune globulin.

AB - Passively acquired antibody may interfere with the active antibody response to live viral vaccines such as measles and rubella. To evaluate the duration of this inhibitory effect, we measured the measles and rubella antibody responses of Apache children immunized with measles, mumps, and rubella vaccine at varying intervals after administration of an immune globulin termed bacterial polysaccharide immune globulin (BPIG). This specific immune globulin contained measles and rubella antibody titers similar to those in standard intramuscularly and intravenously administered immune globulins. Antibody responses to measles vaccine were inhibited for up to 5 months after a BPIG dose of 80 mg IgG per kilogram of body weight, but responses to rubella vaccine were inhibited for only 2 months. Most children who had a decreased measles antibody response to primary measles, mumps, and rubella immunization given 1 1/2 to 4 months after BPIG administration responded to a booster immunization given 6 months after their last BPIG dose. We conclude that high doses of immune globulin (>10 mg/kg) may inhibit the antibody response to measles for more than 3 months. We propose that the interval between administration of immune globulin and measles and rubella immunization be adjusted on the basis of the dose of immune globulin.

UR - http://www.scopus.com/inward/record.url?scp=0027397534&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027397534&partnerID=8YFLogxK

M3 - Article

C2 - 8429432

AN - SCOPUS:0027397534

VL - 122

SP - 204

EP - 211

JO - Journal of Pediatrics

JF - Journal of Pediatrics

SN - 0022-3476

IS - 2

ER -